From patient positioning to injection.
With Pain Medicine Updates.
MAIA supports clinical decision-making.
Introduction Cesarean delivery is one of the most common surgical procedures worldwide, yet roughly 30% of women still experience severe acute pain afterward, even when intrathecal morphine is part of a multimodal regimen. That matters beyond the first postoperative day. Severe early pain after cesarean delivery has been linked to a 2.5-fold higher likelihood of persistent pain and a three-fold higher likelihood of postpartum depression compared with mild pain. Intrathecal morphine (ITM) remains the standard of care, but it comes with a cost: dose-dependent nausea, vomiting, and pruritus can erode the quality of recovery at a time when new mothers need to bond with and care for their newborns. Fascial plane blocks offer an opioid-free alternative. Among them, the lateral quadratus lumborum block (QLB, also called QL1) stands out because it can be performed supine at the end of surgery and has outperformed both the posterior and anterior QL approaches in a recent network meta-analysis. Few trials, however, had directly compared lateral QLB with ITM. A new randomized, double-blind, two-center trial published in the British Journal of Anaesthesia set out to fill that gap, testing lateral QLB alone, ITM alone, and the two combined after cesarean delivery under spinal anesthesia. The results challenge some assumptions about where opioid-free regional techniques fit. Study objective and methods The primary aim was to test whether lateral QLB is noninferior to ITM for quality of recovery (QoR) at 24 hours after cesarean delivery. Secondary aims were to assess noninferiority at 48 hours, compare a wider range of analgesic outcomes between QLB and ITM, and determine whether adding QLB to ITM improves outcomes over ITM alone. The trial was conducted at two Canadian university centers (IWK Health, Halifax, and Maisonneuve-Rosemont Hospital, Montreal) between 2017 and 2023. Participants Non-laboring women undergoing elective or semi-urgent cesarean delivery […]
Regional anesthesia plays an important role in modern perioperative pain management, helping reduce opioid consumption, improve patient comfort, and support postoperative recovery. In thyroid surgery, bilateral superficial cervical plexus blocks (SCPBs) have traditionally been used alongside general anesthesia to provide additional analgesia and reduce postoperative opioid requirements. Previous studies have demonstrated that SCPBs can improve pain control and decrease opioid consumption following thyroidectomy. However, many of these studies were conducted before the widespread adoption of Enhanced Recovery After Surgery (ERAS) protocols, which emphasize standardized, multimodal, opioid-sparing analgesia. Today, patients undergoing thyroidectomy frequently receive combinations of acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), dexamethasone, and local anesthetic infiltration. These interventions already provide effective postoperative pain relief, raising an important clinical question: Does adding a superficial cervical plexus block provide meaningful benefits when comprehensive multimodal analgesia is already in place? A randomized clinical trial by Jegarl and colleagues, published in Anesthesiology in October 2026, investigated this question by evaluating postoperative quality of recovery following thyroidectomy. Rather than focusing exclusively on pain scores or opioid consumption, the researchers assessed patients’ overall recovery experience, including physical comfort, emotional well-being, independence, and pain. Methods The primary objective was to determine whether adding bilateral ultrasound-guided SCPBs with 0.25% bupivacaine to an established thyroidectomy ERAS pathway improved recovery quality on postoperative day one compared with placebo. Researchers conducted a prospective, randomized, double-blind, placebo-controlled superiority trial between November 2023 and February 2026 at two ambulatory surgical sites affiliated with Yale University. Study characteristics Study population: 160 adult patients undergoing thyroidectomy under general anesthesia. Patient eligibility: Adults aged 18 years or older with ASA Physical Status I–III. Study design: Prospective, randomized, double-blind, placebo-controlled trial. Treatment groups: Bupivacaine (n = 78) versus saline placebo (n = 82). Primary assessment: Postoperative day one (POD 1). Primary outcome: Quality of Recovery-40 (QoR-40) score. Interventions […]
The app includes:
The NYSORA Pain Medicine Assistant App provides on-the-go access to expertly-curated techniques, helping you:
The app covers:
The app can be used in multiple ways:
It’s a mobile-friendly reference tool offering: